Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VELCADE in Relapsed Follicular Lymphoma
NCT00715208Phase 2Completed
- Sponsor
- Millennium Pharmaceuticals
- Start
- Sep 2008
- Primary completion
- Feb 2011
- Modality
- Small Molecules, Modified Peptides
- Countries
- 2
01
Overview
A Phase 2 trial of bortezomib in follicular lymphoma (FL), marginal zone lymphoma (MZL), sponsored by Millennium Pharmaceuticals. Started Sep 2008; status: completed.
02
Drugs
bortezomib
03
Conditions
follicular lymphoma (FL)marginal zone lymphoma (MZL)
Beyond the preview
Go deeper on NCT00715208.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00715208.